Fibromyalgia pain does not show up on a scan. No torn muscle, no swollen joint, no injury to point at. The pain is real, it moves around, and it is often everywhere at once. Statistics Canada found that about 2% of Canadians aged 25 and over reported having it, with women more than twice as likely as men to be affected
Fibromyalgia gets more common with age rather than less. The same study found rates above 7% in women aged 60 to 79. Among serving Canadian Armed Forces members, musculoskeletal problems and fibromyalgia counted together were the single most common pain condition reported, at 30.5%.
The absence of a visible cause is the whole problem. It makes the condition hard to diagnose, hard to explain, and hard to treat with drugs built for injuries and inflammation.
Why this kind of pain behaves differently
Think of the nervous system as having a volume knob for pain. In fibromyalgia, the knob is stuck too high. Signals that should register as pressure or warmth come through as pain instead, and genuinely painful signals come through much louder than they should. Researchers call this "central sensitization". Nothing is wrong with the shoulder. Something is wrong with how the shoulder is being reported.
This matters for cannabis because the body already makes its own versions of the compounds in the plant, and that internal system helps set how loudly pain registers in the first place. Adding cannabis is an attempt to turn the knob back down rather than to repair damaged tissue.
The standard prescriptions, drugs like amitriptyline, duloxetine and pregabalin, work on the same idea. They help some people and do very little for others, which is why so many patients go looking elsewhere.
The evidence so far
The largest real-world look came out of Israel. Researchers followed 367 fibromyalgia patients using medical cannabis over six months. Median pain intensity dropped from 9 out of 10 to 5, and 81% of those who stayed on treatment reported a meaningful response. Striking numbers, but there was no placebo group, so some of that improvement belongs to expectation rather than the cannabis itself.
The most useful recent data comes from a small Australian trial published this year. Twenty-four adults took either a 1:1 THC to CBD oil or a placebo before bed for twelve weeks. In the cannabis group, 70% reported at least a 30% drop in pain, against 40% on placebo, and 40% hit the threshold for meaningful overall improvement versus 10 percent on placebo.
The role of THC
One study separates the two main compounds cleanly. A Dutch team gave 20 women with fibromyalgia four different inhaled varieties on separate days: high THC, balanced THC and CBD, CBD only, and a placebo containing neither. Only the varieties containing THC increased how much pressure participants could take before it registered as pain. The CBD-only variety did nothing on that measure, and adding CBD alongside THC actually blunted the effect.
CBD on its own has the weaker record. The largest trial to test it, 200 adults in Denmark taking 50 mg of CBD daily for 24 weeks, found no pain advantage over placebo. That does not make CBD pointless. In a balanced product, it takes the edge off the high and makes a workable THC dose easier to tolerate. As a standalone painkiller for widespread pain, though, the evidence is not there.
Sleep may be the key
The Israeli group reported better sleep. The Australian trial reported better sleep quality. Even the Danish CBD trial found improved nightly rest as its one significant result.
Fibromyalgia sleep is broken in a specific way. People sleep for hours and wake feeling like they did not sleep at all, and pain the next day is reliably worse after a bad night. If cannabis does one thing consistently here, it is holding the night together.
For the neck, hip or knee
Topicals are where many people start, for practical reasons. There is no impairment, so a balm can go on before work or before driving. In a survey of 2,701 people with fibromyalgia, about 60% had tried CBD, most because other medications were not giving enough relief, and 30% to 40% reported meaningful improvement.
Research on topicals is thinner than research on oils and inhaled products, and none of it has been done specifically in fibromyalgia. The closest evidence is a small randomized trial in peripheral nerve pain, where four weeks of topical CBD oil reduced sharp and intense pain compared with placebo.
That fits how a topical works. It acts on the tissue under it rather than reaching the nervous system to do the amplifying, which suits one loud spot: a neck, a hip, a knee that flares after a long day. Most people end up using a topical alongside an oil rather than instead of one.
Start at night
Start at night. Evening dosing sidesteps the fog problem and targets sleep, which is where the evidence is strongest.
Start with an oil rather than an inhaled product, at 2.5 mg of THC or less, in a balanced or CBD-dominant ratio. Oils last through the night and are easy to measure. Inhaled cannabis works within minutes and is better suited to a breakthrough flare during the day.
Increase every three or four nights, not every night. Effects accumulate, and going up too fast is how people end up groggy and convinced it does not work.
Give it a month and write things down: pain out of ten in the morning, hours slept, whether you woke up rested. Memory is unreliable when you are in pain.
Tell your prescriber. Fibromyalgia is usually managed alongside other medications, and your doctor needs to know what you have added.
Relief is a process
Cannabis will not make fibromyalgia go away. The realistic target is a couple of points off a 9, a night that holds, and a morning that starts lower than it used to. Track it honestly for four weeks to see if it works. With patience and consistency, cannabis can become a thoughtful addition to your fibromyalgia management plan, offering some relief while empowering you to take control of your wellness journey.
The most useful recent data comes from a small Australian trial published this year. Twenty-four adults took either a 1:1 THC to CBD oil or a placebo before bed for twelve weeks. In the cannabis group, 70 percent reported at least a 30 percent drop in pain, against 40 percent on placebo, and 40 percent hit the threshold for meaningful overall improvement versus 10 percent on placebo [7]. Twenty-four people settles nothing, and the trial was built mainly to show a larger one could be run. But it points the same way.
THC is doing most of the work
One study separates the two main compounds cleanly. A Dutch team gave 20 women with fibromyalgia four different inhaled varieties on separate days: high THC, balanced THC and CBD, CBD only, and a placebo containing neither. Only the varieties containing THC increased how much pressure participants could take before it registered as pain. The CBD-only variety did nothing on that measure, and adding CBD alongside THC actually blunted the effect [8].
The Israeli cohort and the Australian trial both used THC-containing products.
CBD on its own has the weaker record. The largest trial to test it, 200 adults in Denmark taking 50 mg of CBD daily for 24 weeks, found no pain advantage over placebo [9]. That does not make CBD pointless. In a balanced product it takes the edge off the high and makes a workable THC dose easier to tolerate, As a standalone painkiller for widespread pain, though, the evidence is not there.
Sleep is the most consistent finding
The Israeli group reported better sleep. The Australian trial reported better sleep quality. Even the Danish CBD trial found improved nightly rest as its one significant result [9].
Fibromyalgia sleep is broken in a specific way. People sleep for hours and wake feeling like they did not sleep at all, and pain the next day is reliably worse after a bad night. If cannabis does one thing consistently here, it is holding the night together.
Starting out if you are new to cannabis
Start at night. Evening dosing sidesteps the fog problem and targets sleep, which is where the evidence is strongest.
Start with an oil rather than an inhaled product, at 2.5 mg of THC or less, in a balanced or CBD-dominant ratio. Oils last through the night and are easy to measure. Inhaled cannabis works within minutes and is better suited to a breakthrough flare during the day.
Increase every three or four nights, not every night. Effects accumulate, and going up too fast is how people end up groggy and convinced it does not work.
Give it a month and write things down: pain out of ten in the morning, hours slept, whether you woke up rested. Memory is unreliable when you are in pain.
Tell your prescriber. Fibromyalgia is usually managed alongside other medications, and your doctor needs to know what you have added.
Cannabis will not make fibromyalgia go away. The realistic target is a couple of points off a 9, a night that holds, and a morning that starts lower than it used to. Track it honestly for four weeks, and if nothing has moved, stop and try something else.
Educational content for adults 19+ in Canada. This is not medical advice. Talk to your healthcare provider about your specific situation before starting or changing any treatment.
References
1. Statistics Canada. "Chronic fatigue syndrome, fibromyalgia and multiple chemical sensitivity and employment." Health Reports, March 2017. https://www150.statcan.gc.ca/n1/daily-quotidien/170315/dq170315c-eng.pdf
2. Wolfe F, Ross K, Anderson J, Russell IJ, Hebert L. "The prevalence and characteristics of fibromyalgia in the general population." Arthritis & Rheumatism, 1995;38(1):19-28. https://doi.org/10.1002/art.1780380104
3. Talukdar JR, Zeraatkar D, Thomas A, Busse JW. "An exploration of the increasing prevalence of chronic pain among Canadian veterans: Life After Service Studies 2016 and 2019." Canadian Journal of Pain, 2025. https://doi.org/10.1080/24740527.202
4. 24436314. Vun E, Turner S, Sareen J, Mota N, Afifi TO, El-Gabalawy R. "Prevalence of comorbid chronic pain and mental health conditions in Canadian Armed Forces active personnel." CMAJ Open, 2018;6(4):E528-E536. https://doi.org/10.9778/cmajo.20180093
5. Sagy I, Bar-Lev Schleider L, Abu-Shakra M, Novack V. "Safety and Efficacy of Medical Cannabis in Fibromyalgia." Journal of Clinical Medicine, 2019;8(6):807. https://doi.org/10.3390/jcm8060807
6. Strand NH, Maloney J, Kraus M, et al. "Cannabis for the Treatment of Fibromyalgia: A Systematic Review." Biomedicines, 2023;11(6):1621. https://doi.org/10.3390/biomedicines11061621
7. Kurlyandchik I, et al. "Feasibility, Safety and Preliminary Efficacy of 1:1 THC:CBD Cannabis Oil for Fibromyalgia Symptoms: Results From a Randomised, Double-Blind, Placebo-Controlled Pilot Trial." Pain Research and Management, 2026. https://doi.org/10.1155/prm/7311235
8. van de Donk T, Niesters M, Kowal MA, Olofsen E, Dahan A, van Velzen M. "An experimental randomized study on the analgesic effects of pharmaceutical-grade cannabis in chronic pain patients with fibromyalgia." Pain, 2019;160(4):860-869. https://doi.org/10.1097/j.pain.0000000000001464
9. Rasmussen MU, Christensen R, Waehrens EE, et al. "Cannabidiol versus placebo in patients with fibromyalgia: a randomised, double-blind, placebo-controlled, parallel-group, single-centre trial." Annals of the Rheumatic Diseases, 2026;85(3):566-574. https://doi.org/
10. 1016/j.ard.2025.07.00810. Boehnke KF, Gagnier JJ, Matallana L, Williams DA. "Cannabidiol Use for Fibromyalgia: Prevalence of Use and Perceptions of Effectiveness in a Large Online Survey." The Journal of Pain, 2021;22(5):556-566. https://doi.org/10.1016/j.jpain.2020.12.001
11. Xu DH, Cullen BD, Tang M, Fang Y. "The Effectiveness of Topical Cannabidiol Oil in Symptomatic Relief of Peripheral Neuropathy of the Lower Extremities." Current Pharmaceutical Biotechnology, 2020;21(5):390-402. https://doi.org/10.2174/1389201020666191202111534
